Medigen Vaccine Biologics Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	198.9	715.61	1,393	1,204	1,380	1,679
Short-Term Investments	1,480	1,200	2,364	2,980	800	-
Trading Asset Securities	-	-	-	52.99	53.1	53.17
Cash & Short-Term Investments	1,679	1,916	3,757	4,237	2,233	1,733
Cash Growth	-4.65%	-49.02%	-11.33%	89.77%	28.87%	273.52%
Accounts Receivable	217.37	118.03	149.11	194.4	640.19	4.46
Other Receivables	11.45	9.98	49.74	1.17	0.07	126.25
Receivables	228.81	128.01	198.84	195.57	640.26	130.72
Inventory	477.44	452.06	383.64	903.4	610.84	77.43
Prepaid Expenses	21.06	20.44	13.49	12.37	32.29	17.3
Other Current Assets	46.54	40.79	48.14	113.89	205.07	51.64
Total Current Assets	2,453	2,557	4,401	5,462	3,721	2,010
Property, Plant & Equipment	1,291	1,354	1,385	1,470	1,414	1,343
Long-Term Investments	287.06	407.99	246.13	263.56	54	-
Other Intangible Assets	23.41	29.38	38.3	45.36	52.98	60.01
Other Long-Term Assets	14.26	16.07	22.36	106.83	57.26	77.71
Total Assets	4,068	4,364	6,093	7,348	5,299	3,491
Accounts Payable	11.63	13.39	25.89	109.1	88.53	21.78
Current Portion of Long-Term Debt	-	23.15	1,708	-	-	-
Current Portion of Leases	16.36	16.11	12	11.78	1.99	1.93
Current Unearned Revenue	-	-	-	-	111.41	-
Other Current Liabilities	145.71	161.57	245.73	234.35	237.15	137.27
Total Current Liabilities	173.7	214.22	1,992	355.23	439.09	160.98
Long-Term Debt	-	-	-	1,678	-	-
Long-Term Leases	287.37	299.7	254.36	266.35	183.87	185.85
Other Long-Term Liabilities	-	-	-	19.25	-	2.58
Total Liabilities	461.06	513.92	2,246	2,319	622.95	349.4
Common Stock	3,287	3,287	3,286	3,278	2,129	2,111
Additional Paid-In Capital	348.66	407.38	1,551	2,798	1,135	2,319
Retained Earnings	-2.05	61.02	-1,018	-1,132	1,410	-1,292
Comprehensive Income & Other	-26.83	94.25	27.85	84.03	1.92	3.27
Shareholders' Equity	3,607	3,850	3,847	5,029	4,676	3,141
Total Liabilities & Equity	4,068	4,364	6,093	7,348	5,299	3,491
Total Debt	303.73	338.96	1,974	1,956	185.85	187.78
Net Cash (Debt)	1,375	1,577	1,783	2,281	2,047	1,545
Net Cash Growth	-6.40%	-11.56%	-21.85%	11.45%	32.50%	-
Net Cash Per Share	4.18	4.80	5.43	7.05	6.37	5.57
Filing Date Shares Outstanding	328.75	328.73	328.61	327.84	315.67	313.02
Total Common Shares Outstanding	328.75	328.73	328.61	327.84	315.67	313.02
Working Capital	2,279	2,343	2,410	5,107	3,282	1,849
Book Value Per Share	10.97	11.71	11.71	15.34	14.81	10.04
Tangible Book Value	3,584	3,821	3,808	4,984	4,623	3,081
Tangible Book Value Per Share	10.90	11.62	11.59	15.20	14.65	9.84
Buildings	1,141	1,133	1,130	1,127	1,121	1,117
Machinery	680.46	686.4	650.64	626.59	570.9	388.46
Construction In Progress	25.58	2.57	21.37	14.54	4.7	17.54
Leasehold Improvements	9.35	9.35	3.34	3.03	2.55	1.89

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.